See more : Captor Capital Corp. (CPTR.CN) Income Statement Analysis – Financial Results
Complete financial analysis of Qingdao Baheal Medical INC. (301015.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Qingdao Baheal Medical INC., a leading company in the None industry within the None sector.
You may be interested
- Arcplus Group PLC (600629.SS) Income Statement Analysis – Financial Results
- Helix Exploration PLC (HEX.L) Income Statement Analysis – Financial Results
- Aura Minerals Inc. (ORAAF) Income Statement Analysis – Financial Results
- Parkit Enterprise Inc. (PKT.V) Income Statement Analysis – Financial Results
- STL Technology Co., Ltd. (4931.TWO) Income Statement Analysis – Financial Results
Qingdao Baheal Medical INC. (301015.SZ)
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 7.53B | 7.47B | 7.02B | 5.85B | 4.82B | 3.63B |
| Cost of Revenue | 5.34B | 5.47B | 5.31B | 4.43B | 3.52B | 2.47B |
| Gross Profit | 2.19B | 2.00B | 1.71B | 1.43B | 1.31B | 1.15B |
| Gross Profit Ratio | 29.04% | 26.83% | 24.30% | 24.36% | 27.08% | 31.80% |
| Research & Development | 11.19M | 3.32M | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 49.68M | 44.18M | 33.67M | 36.08M | 0.00 | 0.00 |
| Selling & Marketing | 737.86M | 1.12B | 988.86M | 872.55M | 0.00 | 0.00 |
| SG&A | 1.29B | 1.29B | 1.10B | 1.01B | 971.01M | 804.13M |
| Other Expenses | 3.72M | -303.88K | 2.86M | -8.58M | -1.15M | -4.19M |
| Operating Expenses | 1.30B | 1.29B | 1.09B | 1.01B | 972.15M | 808.32M |
| Cost & Expenses | 6.64B | 6.76B | 6.41B | 5.44B | 4.49B | 3.28B |
| Interest Income | 11.10M | 7.56M | 7.02M | 13.35M | 13.01M | 7.38M |
| Interest Expense | 64.03M | 58.07M | 61.07M | 62.24M | 58.81M | 43.15M |
| Depreciation & Amortization | 58.03M | 61.54M | 53.19M | 22.80M | 22.01M | 22.79M |
| EBITDA | 976.72M | 773.45M | 665.84M | 448.45M | 362.66M | 397.04M |
| EBITDA Ratio | 12.98% | 10.35% | 9.49% | 7.43% | 7.38% | 10.14% |
| Operating Income | 888.20M | 711.91M | 612.65M | 411.75M | 334.08M | 344.80M |
| Operating Income Ratio | 11.80% | 9.53% | 8.73% | 7.04% | 6.93% | 9.51% |
| Total Other Income/Expenses | -14.63M | -43.36M | -64.42M | -40.86M | -41.60M | -6.38M |
| Income Before Tax | 873.58M | 652.95M | 548.24M | 360.24M | 281.84M | 331.10M |
| Income Before Tax Ratio | 11.61% | 8.74% | 7.81% | 6.16% | 5.84% | 9.13% |
| Income Tax Expense | 233.69M | 178.71M | 150.40M | 93.66M | 81.51M | 82.52M |
| Net Income | 656.31M | 506.60M | 421.64M | 272.71M | 209.87M | 258.10M |
| Net Income Ratio | 8.72% | 6.78% | 6.01% | 4.66% | 4.35% | 7.12% |
| EPS | 1.25 | 0.96 | 0.80 | 0.52 | 0.40 | 0.49 |
| EPS Diluted | 1.23 | 0.96 | 0.80 | 0.52 | 0.40 | 0.49 |
| Weighted Avg Shares Out | 525.04M | 525.10M | 525.10M | 525.10M | 525.10M | 525.10M |
| Weighted Avg Shares Out (Dil) | 533.58M | 525.10M | 525.10M | 525.10M | 525.10M | 525.10M |
No news found for: 301015.SZ
Source: https://incomestatements.info
Category: Stock Reports